this variability in immunoreactivity shown by different cell types and structures was comparable to that seen when the same panel of monoclonal antibodies was applied to neuroblastomas and to ganglioneuroblastomas of different degrees of maturation and differentiation .
C0027819
neuroblastomas
C0206718
ganglioneuroblastomas